UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Out of Control: Why Randomized Trials of Factor Concentrates Are So Elusive

Journal of cardiothoracic and vascular anesthesia, 2021-09, Vol.35 (9), p.2659-2661

2021

Volltextzugriff (PDF)

Combination of aptamer and drug for reversible anticoagulation in cardiopulmonary bypass

Nature biotechnology, 2018-08, Vol.36 (7), p.606-613

2018

Volltextzugriff (PDF)

A rapid pro-hemostatic approach to overcome direct oral anticoagulants

Nature medicine, 2016-08, Vol.22 (8), p.924-932

2016

Volltextzugriff (PDF)

Hematologic Consequences of the Coronavirus Crisis—Focus on Relevant Clues and Complications for the Perioperative Cardiothoracic and Vascular Community

Journal of cardiothoracic and vascular anesthesia, 2020-12, Vol.34 (12), p.3189-3192

2020

Volltextzugriff (PDF)

Left Coronary Artery Reimplantation for Repair of Anomalous Origin of the Left Coronary Artery From the Pulmonary Artery in an Adult

Journal of cardiothoracic and vascular anesthesia, 2023-10, Vol.37 (10), p.2098-2108

2023

Volltextzugriff (PDF)

Rendering factor Xa zymogen-like as a therapeutic strategy to treat bleeding

Current opinion in hematology, 2017-09, Vol.24 (5), p.453-459

2017

Volltextzugriff (PDF)

Opioid-Free Cardiac Surgery: A Multimodal Pain Management Strategy With a Focus on Bilateral Erector Spinae Plane Block Catheters

Journal of cardiothoracic and vascular anesthesia, 2022-12, Vol.36 (12), p.4523-4533

2022

Volltextzugriff (PDF)

Enzymatic Dissolution of Calcium and Struvite Crystals: In Vitro Evaluation of Biochemical Requirements

Urology (Ridgewood, N.J.), 2011-09, Vol.78 (3), p.721.e13-721.e17

2011

Volltextzugriff (PDF)

Kinetic Mechanism and Structural Requirements of the Amine-Catalyzed Decarboxylation of Oxaloacetic Acid

Journal of organic chemistry, 2009-01, Vol.74 (1), p.144-152

2009

Volltextzugriff (PDF)

Administration of Andexanet Alfa for Direct Factor Xa Inhibitor Reversal Precludes Therapeutic Heparinization for Cardiopulmonary Bypass

Blood, 2019-11, Vol.134 (Supplement_1), p.3640-3640

2019

Volltextzugriff (PDF)

Prothrombin Membrane Binding and Gla-Dependent Function Are Not Required for Effective Hemostasis In Vivo

Blood, 2015-12, Vol.126 (23), p.124-124

2015

Volltextzugriff (PDF)

RNA Aptamer Against FXa Synergizes with FXa Catalytic Site Inhibitors to Effectively and Reversibly Anticoagulate Blood in an Ex Vivo Oxygenator Circuit

Blood, 2016-12, Vol.128 (22), p.3823-3823

2016

Volltextzugriff (PDF)

Regulation of Factor VIII By Activated Protein C: Assessment In Vitro and In Vivo

Blood, 2017-12, Vol.130, p.3650-3650

2017

Volltextzugriff (PDF)

Zymogen-like FXa Variant As a Short-Acting Warfarin Reversal Agent: Pre-Clinical Evaluation and Mechanism of Action

Blood, 2014-12, Vol.124 (21), p.4262-4262

2014

Volltextzugriff (PDF)

Zymogen-like FXa Is a Potent Bypassing Agent for Reversal of Direct FXa Inhibitors in Vivo

Blood, 2014-12, Vol.124 (21), p.582-582

2014

Volltextzugriff (PDF)

Zymogen-Like FXa Is An Effective Pro-Hemostatic To Reverse The Anticoagulant Effects Of Direct FXa Inhibitors

Blood, 2013-11, Vol.122 (21), p.2383-2383

2013

Volltextzugriff (PDF)

A new mechanism-driven bypassing strategy for direct factor Xa inhibitors reveals an unexpected property of target specific anticoagulants

Thalji, Nabil K

2015

Volltextzugriff (PDF)

1 – 17 von 17

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(13)

Publikationsform

Artikel
(16)
Dissertationen
(1)

Sprache

Englisch
(17)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Out of Control: Why Randomized Trials of Factor Concentrates Are So Elusive

Combination of aptamer and drug for reversible anticoagulation in cardiopulmonary bypass

A rapid pro-hemostatic approach to overcome direct oral anticoagulants

Hematologic Consequences of the Coronavirus Crisis—Focus on Relevant Clues and Complications for the Perioperative Cardiothoracic and Vascular Community

Left Coronary Artery Reimplantation for Repair of Anomalous Origin of the Left Coronary Artery From the Pulmonary Artery in an Adult

Rendering factor Xa zymogen-like as a therapeutic strategy to treat bleeding

Opioid-Free Cardiac Surgery: A Multimodal Pain Management Strategy With a Focus on Bilateral Erector Spinae Plane Block Catheters

Enzymatic Dissolution of Calcium and Struvite Crystals: In Vitro Evaluation of Biochemical Requirements

Kinetic Mechanism and Structural Requirements of the Amine-Catalyzed Decarboxylation of Oxaloacetic Acid

Administration of Andexanet Alfa for Direct Factor Xa Inhibitor Reversal Precludes Therapeutic Heparinization for Cardiopulmonary Bypass

Prothrombin Membrane Binding and Gla-Dependent Function Are Not Required for Effective Hemostasis In Vivo

RNA Aptamer Against FXa Synergizes with FXa Catalytic Site Inhibitors to Effectively and Reversibly Anticoagulate Blood in an Ex Vivo Oxygenator Circuit

Regulation of Factor VIII By Activated Protein C: Assessment In Vitro and In Vivo

Zymogen-like FXa Variant As a Short-Acting Warfarin Reversal Agent: Pre-Clinical Evaluation and Mechanism of Action

Zymogen-like FXa Is a Potent Bypassing Agent for Reversal of Direct FXa Inhibitors in Vivo

Zymogen-Like FXa Is An Effective Pro-Hemostatic To Reverse The Anticoagulant Effects Of Direct FXa Inhibitors

A new mechanism-driven bypassing strategy for direct factor Xa inhibitors reveals an unexpected property of target specific anticoagulants

Suchergebnisse filtern